OBIO
Orchestra BioMed Holdings, Inc.
-0.19 (-3.16%)5.82USD152K成交股數350M市值–本益比(近四季)10.9股價營收比-89.5%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 88K-89% | 110K-87% | 30.9M+3032% | 861K+11% | 836K+35% | 868K+231% | 987K+136% | 778K-15% | 620K | 262K | 419K | 915K |
| 營業成本 | 25K | 32K | 51K | 49K | 46K | 44K | 68K | 44K | 34K | 47K | 41K | 54K |
| 毛利 | 63K-92% | 78K-91% | 30.9M+3259% | 812K+11% | 790K+35% | 824K+283% | 919K+143% | 734K-15% | 586K | 215K | 378K | 861K |
| 毛利率 | 71.6% | 70.9% | 99.8% | 94.3% | 94.5% | 94.9% | 93.1% | 94.3% | 94.5% | 82.1% | 90.2% | 94.1% |
| 研發費用 | 16.6M | 15.8M | 16.8M | 14.0M | 13.9M | 13.5M | 11.6M | 11.1M | 9.1M | 8.5M | 8.6M | 8.5M |
| 銷售管理費用 | 5.8M | 6.4M | 7.3M | 7.1M | 6.3M | 6.3M | 5.7M | 6.5M | 5.9M | 4.2M | 6.3M | 5.3M |
| 營業利益 | −22.4M+16% | −22.1M+17% | 6.8M-141% | −20.3M+20% | −19.3M+34% | −18.9M+52% | −16.3M+13% | −16.9M+30% | −14.4M | −12.5M | −14.5M | −13.0M |
| 營業利益率 | -25,404.5% | -20,069.1% | 21.8% | -2,359.2% | -2,311.8% | -2,179.8% | -1,655.7% | -2,167.0% | -2,326.3% | -4,763.7% | -3,466.3% | -1,416.0% |
| 稅後淨利 | −23.8M+23% | −20.7M+10% | 6.2M-140% | −20.8M+30% | −19.4M+44% | −18.8M+46% | −15.4M+16% | −16.0M+33% | −13.5M | −12.8M | −13.3M | −12.0M |
| 淨利率 | -26,994.3% | -18,810.0% | 20.2% | -2,419.0% | -2,316.1% | -2,160.7% | -1,562.9% | -2,054.0% | -2,171.5% | -4,892.4% | -3,178.0% | -1,316.5% |
| 稀釋 EPS | -0.38-24% | -0.33-33% | 0.28-168% | -0.40-11% | -0.50+32% | -0.49+40% | -0.41+8% | -0.45+29% | -0.38 | -0.35 | -0.38 | -0.35 |
| 稀釋股數 | 63.8M | 62.7M | 47.7M | 52.2M | 38.4M | 38.2M | 37.6M | 35.8M | 35.8M | 33.2M | 35.2M | 34.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 20.5M | 28.4M | 34.7M | 42.0M | 18.7M | 18.3M | 25.6M | 23.7M | 23.3M | 30.6M | 19.1M | 16.4M |
| 應收帳款 | 51K | 84K | 95K | 52K | 83K | 89K | 115K | 80K | 67K | 99K | 86K | 171K |
| 存貨 | 250K | 277K | 310K | 365K | 185K | 135K | 234K | 70K | 115K | 146K | 137K | 178K |
| 總資產 | 116M | 101M | 115M | 105M | 42.8M | 59.1M | 75.3M | 72.4M | 82.6M | 95.2M | 116M | 126M |
| 有息負債 | – | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | – | – | – | – | 10.0M | 10.0M |
| 總負債 | 86.3M | 49.7M | 51.5M | 61.1M | 42.5M | 42.2M | 29.1M | 28.3M | 25.4M | 27.2M | 36.7M | 36.4M |
| 股東權益 | 19.3M | 41.2M | 53.6M | 43.7M | 295K | 16.9M | 46.2M | 44.1M | 57.2M | 68.0M | 79.7M | 89.4M |
| 負債比 | 74.6% | 49.4% | 44.8% | 58.3% | 99.3% | 71.5% | 38.6% | 39.0% | 30.8% | 28.5% | 31.5% | 29.0% |
| 淨現金(現金 − 有息負債) | – | 13.4M | 19.7M | 27.0M | 3.7M | 3.3M | – | – | – | – | 9.1M | 6.4M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −22.2M+33% | – | – | – | −16.6M | – | – | −13.1M | – | – | – |
| 資本支出 | – | 184K | – | – | – | 112K | – | – | 8K | – | – | – |
| 自由現金流 | – | −22.4M+34% | – | – | – | −16.7M | – | – | −13.1M | – | – | – |
| 折舊攤銷 | – | 90K | – | – | – | 83K | – | – | 74K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -20,320.0% | – | – | – | -1,927.2% | – | – | -2,116.5% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 33.5M
| Partnership Revenue | 32.9M | 98.2% | +1539.5% |
|---|---|---|---|
| 產品 | 611K | 1.8% | -3.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 33.5M | +1169.2% | −52.7M | -157.4% | -1.11 | −49.5M |
| FY2024 | 2.6M | -4.4% | −61.0M | -2,313.3% | -1.66 | −50.8M |
| FY2023 | 2.8M | -21.9% | −49.1M | -1,779.7% | -1.48 | −46.2M |
| FY2022 | 3.5M | – | −33.6M | -951.3% | -2.24 | −29.9M |
| FY2021 | – | – | −379K | –% | -0.02 | – |